Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGIV-C in generalized myasthenia gravis
NCT02473952Phase 2Completed
- Sponsor
- Grifols
- Start
- Aug 2015
- Primary completion
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 2 trial of gamunex in myasthenia gravis (MG), sponsored by Grifols. Started Aug 2015; status: completed.
02
Drugs
gamunex
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT02473952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473952.